Catalent Capacity Update January 2025: Large Molecule Development

Catalent offers an extensive suite of analytical services designed to support both traditional biologics and emerging modalities, including ADCs, cell and gene therapies, mRNA, vaccines, and more. These services encompass cell banking, characterization, release and stability testing, reference standard aliquoting, qualification, and beyond, providing comprehensive support for the development and production of biotherapeutics.

Join Vincy Abraham, Director of Biologics Analytical Services, to explore how Catalent’s deep expertise and advanced capabilities enable customized analytical solutions that address the unique needs of your biotherapeutics, ensuring quality, precision, and regulatory compliance at every stage.